M. Beer - Concepedia

Author

M. Beer

Metaxa Hospital

Also Known As

M Beer, M de Beer, M. Beer, MARIO BEER, Mario Beer, Marios Beer, Meir Beer, Vasilios Avramidis

Publications

704

Citations

H-Index

Concepts

All Affiliations

Metaxa Hospital Hellenic Cooperative Oncology Group AHEPA University Hospital Hospital Agioi Anargyroi New York Medical College

About

M. Beer is an author at Metaxa Hospital specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	14	468
2	Health Sciences	1	1	54
3	Cell Biology	1	1	27
4	Immunology	1	1	31
5	Obstetrics	1	1	17

M. Beer

Publications

618

Citations

H-Index

Page 1

	Year	Citations
Factors associated with oesophageal cancer in Soweto, South Africa I Segal, SG Reinach, M. Beer British Journal of Cancer Surgical OncologyEsophagusAerodigestive CancerEsophageal CancerMedicine	1988	84
Phase I study of carboplatin given on a five-day intravenous schedule. Marcel Rozencweig, Claude Nicaise, M. Beer, Journal of Clinical Oncology Twenty-six Adult PatientsOncologyGastrointestinal OncologyMedicineBioanalysis	1983	64
A randomized trial of high- vs standard-dose mitoxantrone with cytarabine in elderly patients with acute myeloid leukemia EJ Feldman, Karen Seiter, Lloyd E. Damon, Leukemia Hematological MalignancyElderly PatientsMedicineAcute Myeloid LeukemiaMixed-phenotype Acute Leukemia	1997	54
Phase I/II Pilot Study of Intravesical Apaziquone (EO9) for Superficial Bladder Cancer Rajiv Puri, Victor Palit, Paul M. Loadman, The Journal of Urology	2006	45
Response of Multiple Recurrent TaT1 Bladder Cancer to Intravesical Apaziquone (EO9): Comparative Analysis of Tumor Recurrence Rates Arun K. Jain, Roger M. Phillips, G. Lenaz, Urology Tumor Recurrence RatesUrologySurgical OncologyUrologic Cancer EpidemiologyIntravesical Apaziquone	2009	41
Fluconazole versus Amphotericin B in the Treatment of Esophageal Candidiasis in Cancer Patients Diana Lake, J. Kumweiler, M. Beer, Chemotherapy	1996	36
[BCG vs interferon A for prevention of recurrence of superficial bladder cancer. A prospective randomized study]. T. Kälble, M. Beer, U. Ikinger, PubMed	1994	32
Single and double autotransplants for relapsing/refractory Hodgkin’s disease: results of two consecutive trials Tauseef Ahmed, D.N.W. Lake, M. Beer, Bone Marrow Transplantation TransplantationImmunodeficienciesDouble AutotransplantsImmunologyConsecutive Trials	1997	31
Original article: Subsets of tumors responsive to cisplatin or carboplatin combinations in patients with carcinoma of unknown primary site Nicholas Pavlidis, P. Kosmidis, Dimosthenis Skarlos, Annals of Oncology Malignant DiseaseMedicinePathologyMolecular OncologyOriginal Article	1992	28
A comparative study of cisplatin and vinblastine versus ifosfamide, cisplatin and vinblastine in non-operable non-small-cell lung cancer P. Kosmidis, N. Mylonakis, D. Skarlos, Annals of Oncology Vinblastine Versus IfosfamideMedicineCancer ManagementPathologyBronchial Neoplasm	1994	28

Page 1